Brazil has championed the cause of hepatitis on the world stage for many years and has pushed for an intensified and global hepatitis response. Brazil has therefore been chosen to partner and host the World Hepatitis Summit 2017, in recognition of the country’s ongoing national initiatives and consistent international leadership in the area of viral hepatitis.
Nationally, Brazil has been providing care and assistance for patients of viral hepatitis through the public health system since 2002. The Brazilian Ministry of Health recently launched innovative interferon-free guidelines for the treatment of hepatitis C which allows the treatment of formerly excluded populations. Moreover, the Ministry of Health have succeeded in reducing the price of chronic hepatitis C medication by over 90% from the original price.
In 2010, at the 63rd World Health Assembly, Brazil were instrumental in putting hepatitis in the spotlight by proposing the first ever viral hepatitis resolution (WHA63.18) which established World Hepatitis Day as one of only four WHO disease-specific days.
In 2014, at the 67th World Health Assembly, Brazil co-sponsored a new WHO resolution (WHA67.6) which urged governments to develop and implement coordinated, multisectoral national strategies for preventing, diagnosing and treating viral hepatitis. This resolution called upon WHO to examine the feasibility of the elimination of hepatitis B and hepatitis C with a view to setting global targets.
In 2015, together with WHO and PAHO, Brazil hosted and co-sponsored the Latin American and Caribbean Consultation on Global Strategies in the Health Area for HIV, STIs and viral hepatitis.
Brazil have increased the number of those eligible for free hepatitis B vaccinations from those up to the age of 49 in 2013 to universal free access in 2016.
The Ministry of Health is developing a national strategy focused on hepatitis B and D in the Brazilian Amazon Region to promote the prevention and control of viral hepatitis in the Amazon Basin.